Scemblix (Asciminib)
- Medicine Name: Scemblix
- Generic Name: Asciminib
- Dosage Form & Strength: Tablets: 20 mg/40 mg
- Manufactured By: Novartis Pharmaceuticals Corporation
Scemblix is a kinase inhibitor used for the treatment of adult patients with: Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with 2 or more tyrosine kinase inhibitors (TKIs). Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP) with the T315I mutation.
Recommended Dosage: The recommended dosage in Ph+ CML in CP is 80 mg orally taken once daily or 40 mg twice daily and in Ph+ CML in CP with the T315I Mutation is 200 mg taken orally twice daily. Avoid food consumption for at least 2 hours before and 1 hour after taking the scemblix tablets. Swallow tablets of Scemblix whole, without breaking, crushing, or chewing.
- Neutropenia, thrombocytopenia, and anemia have emerged in patients receiving Asciminib. Complete blood counts need to be performed every 14 days for the first 3 months of treatment and monthly thereafter. Assess patients for signs/symptoms of myelosuppression.
- Assess serum lipase and amylase levels monthly during therapy with Scemblix 20mg / 40mg. Assess patients for signs/symptoms of pancreatic toxicity. More frequent monitoring needs to be performed in patients with a history of pancreatitis.
- Hypertension appeared in patients with asciminib treatment. Monitor and manage hypertension using standard antihypertensive therapy during treatment with asciminib; for Grade 3 or higher hypertension, temporarily withhold, reduce dose, or permanently discontinue therapy depending on persistence of hypertension.
- Hypersensitivity appeared in patients receiving Scemblix 40mg / 20mg. Monitor patients for signs and symptoms of hypersensitivity and initiate apt treatment; for Grade 3 or higher hypersensitivity, temporarily withhold, reduce dose, or permanently discontinue therapy on behalf of persistence of hypersensitivity.
- Cardiovascular toxicity (including arterial thrombotic, embolic conditions, ischemic cardiac and CNS conditions) and cardiac failure occurred in patients taking therapy with Scemblix. Assess patients with a history of cardiovascular risk factors for cardiovascular signs/symptoms.
- Depending on findings and its mechanism of action, asciminib can cause fetal harm if administered to a pregnant woman. Verify the pregnancy status of females of reproductive age prior to starting treatment with Asciminib.
What documents are required to import SCEMBLIX to India?
SCEMBLIX (asciminib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation needed in order to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients Identity Proof (issued by Gov of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is SCEMBLIX available in India?
SCEMBLIX (asciminib tablet) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
On availability of Scemblix in India (Hyderabad, Mumbai, Kolkata, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
SCEMBLIX can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of SCEMBLIX (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at info@indianpharmanetwork.in for Scemblix price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the SCEMBLIX (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Scemblix®?
Asciminib is Generic Name for the trade name drug Scemblix®.
What is the Manufacturer Name of Scemblix®?
Scemblix® is manufactured by Novartis Pharmaceuticals Corporation.
Is Scemblix® approved by the FDA?
Yes, Scemblix® is approved by the FDA. Date of approval: October 29, 2021.
What is Scemblix®?
Scemblix is an FDA approved medication used to treat adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
What is the dosage and form of Scemblix® supplied?
Scemblix® is supplied as film-coated Tablets: 20 mg and 40 mg for oral administration.
What are the most common side effects due to Scemblix®?
Most common side effects due to Scemblix include: rash, upper respiratory tract infections, musculoskeletal pain, nausea, diarrhea, and fatigue.
How much does Scemblix cost in India?
The scemblix cost in India is very reasonable. In order to procure this Ph+ CML medication authentically, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Scemblix®?
Store scemblix tablets at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). Dispense and store in the original container to protect from moisture.
What are the Highlights of prescribing information for Scemblix®?
Click Here to download full Scemblix prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.